Trademark Overview
On Wednesday, June 14, 2023, a trademark application was filed for LIVING HYPOPARA with the United States Patent and Trademark Office. The USPTO has given the LIVING HYPOPARA trademark a serial number of 98041740. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, May 29, 2024. This trademark is owned by Ascendis Pharma Endocrinology Division A/S. The LIVING HYPOPARA trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, and health care; Publication of non-downloadable electronic publications in the nature of ad boards, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Educational services, namely, conducting educational programs for patients and healthcare providers related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders
Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders
Providing and sharing of medical information and advice relating to growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, medical screening, medicine, health and pharmaceutical products; Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders